Search research articles
Contact Us
Filters
Showing results (111-120 of 178) with videos related to
Page
of 18
Sort By:
Research Square
|
April 3, 2026
High genetic diversity, clonal activation of hypnozoites and relapse of Plasmodium vivax isolates in low-transmission setting of Ethiopia
Hallelujah Getachew, Daibin Zhong, Kassahun Habtamu, et al.
Parasites & Vectors
|
February 6, 2024
Higher outdoor mosquito density and Plasmodium infection rates in and around malaria index case households in low transmission settings of Ethiopia: Implications for vector control
Ashenafi Abossie, Assalif Demissew, Hallelujah Getachew, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 17, 2021
Individual Efficacy and Community Impact of Ivermectin, Diethylcarbamazine, and Albendazole Mass Drug Administration for Lymphatic Filariasis Control in Fiji: A Cluster Randomized Trial
Myra Hardy, Josaia Samuela, Mike Kama, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 21, 2020
Pharmacokinetic and safety study of co-administration of albendazole, diethylcarbamazine, Ivermectin and azithromycin for the integrated treatment of Neglected Tropical Diseases
Lucy N John, Catherine Bjerum, Pere Millat Martinez, et al.
The Journal of Infectious Diseases
|
October 12, 2012
Placental infection with Plasmodium vivax: a histopathological and molecular study
Alfredo Mayor, Azucena Bardají, Ingrid Felger, et al.
Malaria Journal
|
November 28, 2024
Profiling vivax malaria incidence, residual transmission, and risk factors using reactive case detection in low transmission settings of Ethiopia
Ashenafi Abossie, Hallelujah Getachew, Assalif Demissew, et al.
The Lancet. Infectious Diseases
|
May 9, 2025
Moxidectin combination therapies for lymphatic filariasis: an open-label, observer-masked, randomised controlled trial
Guibehi Benjamin Koudou, Catherine M Bjerum, Foungoye Allassane Ouattara, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 30, 2011
Fy(a)/Fy(b) antigen polymorphism in human erythrocyte Duffy antigen affects susceptibility to Plasmodium vivax malaria
Christopher L King, John H Adams, Jia Xianli, et al.
Plos Neglected Tropical Diseases
|
March 10, 2025
Impact of mass drug administration with ivermectin, diethylcarbamazine, and albendazole for lymphatic filariasis on hookworm and Strongyloides stercoralis infections in Papua New Guinea
Jannet A Tobon Ramos, Tobias Maure, Lenore Carias, et al.
The American Journal of Tropical Medicine and Hygiene
|
June 9, 2007
The risk of malarial infections and disease in Papua New Guinean children
Pascal Michon, Jennifer L Cole-Tobian, Elijah Dabod, et al.
Page
of 18
Search research articles
Search
Showing results (111-120 of 178) with videos related to
Sort By:
Page
of 18
Research Square
|
April 3, 2026
High genetic diversity, clonal activation of hypnozoites and relapse of Plasmodium vivax isolates in low-transmission setting of Ethiopia
Hallelujah Getachew, Daibin Zhong, Kassahun Habtamu, et al.
Parasites & Vectors
|
February 6, 2024
Higher outdoor mosquito density and Plasmodium infection rates in and around malaria index case households in low transmission settings of Ethiopia: Implications for vector control
Ashenafi Abossie, Assalif Demissew, Hallelujah Getachew, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 17, 2021
Individual Efficacy and Community Impact of Ivermectin, Diethylcarbamazine, and Albendazole Mass Drug Administration for Lymphatic Filariasis Control in Fiji: A Cluster Randomized Trial
Myra Hardy, Josaia Samuela, Mike Kama, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 21, 2020
Pharmacokinetic and safety study of co-administration of albendazole, diethylcarbamazine, Ivermectin and azithromycin for the integrated treatment of Neglected Tropical Diseases
Lucy N John, Catherine Bjerum, Pere Millat Martinez, et al.
The Journal of Infectious Diseases
|
October 12, 2012
Placental infection with Plasmodium vivax: a histopathological and molecular study
Alfredo Mayor, Azucena Bardají, Ingrid Felger, et al.
Malaria Journal
|
November 28, 2024
Profiling vivax malaria incidence, residual transmission, and risk factors using reactive case detection in low transmission settings of Ethiopia
Ashenafi Abossie, Hallelujah Getachew, Assalif Demissew, et al.
The Lancet. Infectious Diseases
|
May 9, 2025
Moxidectin combination therapies for lymphatic filariasis: an open-label, observer-masked, randomised controlled trial
Guibehi Benjamin Koudou, Catherine M Bjerum, Foungoye Allassane Ouattara, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 30, 2011
Fy(a)/Fy(b) antigen polymorphism in human erythrocyte Duffy antigen affects susceptibility to Plasmodium vivax malaria
Christopher L King, John H Adams, Jia Xianli, et al.
Plos Neglected Tropical Diseases
|
March 10, 2025
Impact of mass drug administration with ivermectin, diethylcarbamazine, and albendazole for lymphatic filariasis on hookworm and Strongyloides stercoralis infections in Papua New Guinea
Jannet A Tobon Ramos, Tobias Maure, Lenore Carias, et al.
The American Journal of Tropical Medicine and Hygiene
|
June 9, 2007
The risk of malarial infections and disease in Papua New Guinean children
Pascal Michon, Jennifer L Cole-Tobian, Elijah Dabod, et al.
Page
of 18